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Abstract 
Background: Several studies have associated elevated C-reactive protein (CRP) levels to the 
occurrence of atrial fibrillation (AF). We sought to estimate the frequency and prognostic 
impact of AF in patients with bacteremia, and to study the possible association between AF 
and C-reactive protein (CRP) in this population.  
Materials and Methods: We retrospectively evaluated patient-charts of patients with 
bacteremia with E.coli or S.pneumoniae admitted to Aker Universitiy Hospital in Oslo 
throughout the period 1994 to 2004. Variables on known cardiac risk factors for AF, signs of 
AF, mode of conversion of AF, and, if applicable, date of death, were registered. Initial CRP 
values were categorized into 4 strata. Odds ratios (ORs) of the 3 highest CRP-categories 
compared with the lowest ones were obtained from logistic models adjusting for known 
cardiac risk factors for AF. Cox regression analysis was used to compare new-onset AF and 
death during the first two weeks after hospitalization.  
Results: 677 patient charts were studied. 104 patients (15.4%) had new-onset AF. Peak 
incidence of new-onset AF occurred on the day of admission. Peak CRP values were reached 
during the two next days. High CRP level at admission did not predict the occurrence of AF. 
The observed mortality was higher among patients with new-onset AF (p=0.04) during the 
first two weeks after hospitalization. 
Conclusions: The frequency of new-onset AF in bacteremia is substantial. Initial CRP levels 
do not predict new-onset AF. In patients with bacteremia, new-onset AF is associated with 
increased mortality.  
Keywords: C-reactive protein / atrial fibrillation / bacteremia /  
inflammation / arrhythmia / human 
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Introduction 
 
Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting predominantly 
elderly patients. Its prevalence in a population above 65 years is approximately 5%, 
representing an increase of prevalence over the last decades which is not expected 
to come to a halt in the near future.1 Despite the identification of cardiac risk factors 
for developing AF such as valvular heart disease, congestive heart failure or 
hypertensive heart disease1, not all pathophysiologic mechanisms have yet been fully 
elucidated. A correlation of an inflammatory state with the occurrence of AF was 
proposed in 19972, and recently a growing number of studies has shown an 
association between elevated C-reactive protein (CRP) levels and paroxysmal as 
well as permanent AF.3-6 In fact, CRP is not only associated with the existence of AF 
but it may also predict future development of AF.7  
In this context the question remains whether CRP also could be a useful marker for 
the development of AF in systemic infection, which undoubtedly represents an acute 
inflammatory reaction. We therefore retrospectively evaluated patients with 
bacteremia representative of a definite invasive infection, E.coli and S.pneumoniae, 
thus eliminating or at least reducing false-positive blood cultures due to, e.g., skin 
flora contamination. After adjusting for known cardiac risk factors for AF, we sought 
to determine if CRP might be a predictor of new-onset AF in patients with bacteremia. 
We also compared the mortality in the groups with and without new-onset AF during 
the first two weeks after hospitalization. 
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Methods 
Objectives and study design  
The objectives of this study were to examine the frequency of AF in a patient cohort 
with a definite invasive infection, and to determine whether CRP may be an 
independent risk factor for developing AF. Further, we sought to clarify whether new-
onset AF has a prognostic impact in patients with bacteremia. We also wanted to 
determine whether corticosteroid therapy reduce the risk of developing new-onset AF 
in bacteremia. 
By comprehensively registering all well-documented cardiac risk factors in this 
population, we attempted to correct for those in our regression analysis. The study 
was designed as a retrospective study of all patient-charts of patients admitted to 
Aker University Hospital in Oslo, Norway, throughout the period 1994 to 2004, with 
bacteremia caused by either E.coli or S.pneumoniae. The Regional Ethics 
Committee, as well as the Population Data Registry Authority of Norway approved 
the study. 
 
Study population 
The inclusion criteria in our study were as follows: Positive hemoculture of E.coli or 
S.pneumoniae, in blood drawn on the day of admission or the day after, and a 
measured CRP at admission. Patients with bacteremia with E.coli or S.pneumoniae 
were selected from the database of our bacteriology laboratory. This database had 
existed since1994. Our patient material was restricted to patients who had 
documented bacteremia on the day of admission or the day after, and who had at 
least one CRP measurement on the day of admission. The patient-charts were 
retrieved from the hospital’s central archive.  
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Clinical variables 
Anamnestic information. Information on established risk factors for AF was 
registered. Particularly the following pre-existing conditions were examined: 
permanent AF, paroxysmal AF, myocardial infarction, angina pectoris, congestive 
heart failure, arterial hypertension, cardiomyopathy, stroke, and pulmonary embolism.  
Symptoms of new-onset AF, such as palpitations and dyspnea, were registered. We 
also registered if the patient were on warfarin treatment, or had been taking 
corticosteroids in a dose of 10mg or more per day on a regular basis prior to 
admission. 
Documentation of AF and mode of conversion to sinus rhythm. AF was stated if 
found on a 12-lead ECG. The date of start of new-onset AF was noted. The mode of 
conversion to sinus rhythm (SR) was registered, as well as the date of conversion. 
Chest X-ray and echocardiography. Pulmonary venous congestion was stated if 
noted in the description of the last chest X-ray taken before the index hospitalization. 
If an echocardiography was performed within a reasonable time before the hospital 
stay, we registered left ventricular hypertrophy (LVH) and/or a measurement of the 
left ventricular ejection fraction (LVEF). 
Definitions of AF used. The AF definition followed the newly published AHA-ACC-
ESC guideline.8  Paroxysmal AF was defined as self-terminating, persistent AF was 
defined as requiring electrical or pharmacologic intervention to restore sinus rhythm, 
and permanent AF as the inability for this kind of intervention to restore sinus rhythm. 
Patients admitted with a history of previously known paroxysmal AF were also 
registered as having new-onset AF if AF was documented during the index-
hospitalization, while patients with a previously known permanent AF were excluded.  
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CRP-measurements 
The CRP values of the individual patients were retrieved from the databases of the 
Clinical Chemistry Laboratory. These CRP-measurements had been performed by 
immunoturbidometric assay for automated clinical chemistry analyzers (Roche 
Diagnostics, Mannheim, Germany). The CRP-levels on the day of admission were 
categorized into the following strata: 0-50 mg/L, 51-150 mg/L, 151-251 mg/L, and 
above 250 mg/L. The point in time of later CRP-measurements was expressed in 2 
additional categories: CRP2 (i.e., CRP measured on the second or third day of 
hospital stay), and CRP3 (i.e., CRP measured between day 4 and 7 of the hospital 
stay). 
 
Analysis of blood culture  
Data on positive blood cultures with S.pneumoniae, and/or E.coli were retrieved from 
our bacteriology laboratory database. In case of a patient having more than one 
episode of bacteremia, either the first or the last episode was registered. A small 
number of patients had episodes of both E.coli and S.pneumoniae bacteremia. Here 
the two bacteria types were selected every other time. By this procedure each patient 
was represented uniquely, by only one episode of bacteremia, and by only one 
bacterium. The blood culture system used in the period was Bactec 9240 (Becton & 
Dickinson, Sparks, MD, USA). Further identification of the positive blood cultures 
followed standard procedures of the laboratory. Growth of possible S.pneumoniae 
was confirmed by typical fenotype and sensitivity to optochin and later also by 
agglutination test (Slidex pneumo-Kit, BioMériux, Lyon, France). E.coli was identified 
by a three tube method for identification of Gram-negative rods,9  or by api20E 
(BioMériux). 
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Statistics 
Chi-square tests were used to compare groups with categorical data. Odds ratios 
(ORs) for the three highest CRP-categories compared with the lowest with 95% 
confidence intervals (95% CIs) were obtained from logistic models adjusting for 
known cardiac risk factors for AF. Tests for trend were obtained from logistic models 
treating CRP-categories as a continuous variable. Cox regression was used 
comparing new onset AF and death during the first two weeks after hospitalization. 
All tests were computed using the SPSS - 14.0 software (SPSS Inc., Chicago, IL, 
USA). P-values <0.05 were considered significant. Receiver-operating characteristic 
(ROC) curves were used to evaluate the overall diagnostic performance of measured 
CRP-levels. 
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Results 
759 patients fulfilled the inclusion criteria. Of these 82 patients were excluded either 
because of inadequate information in the charts, or due to the fact that the patient-
chart was unavailable (i.e., patients were hospitalized concomitantly with our chart 
study period). This resulted in a total patient cohort of 677 patients. 
Baseline characteristics  
Baseline characteristics of the cohort are outlined in Table 1. The age of the patients 
ranged from 20 to 100 years (mean 69.1 years). 57% of the patients were women 
and 43% were men. E.coli bacteremia was documented in 66.5% of the patients and 
S.pneumoniae in 33.5%.   
New-onset AF 
New-onset AF occurred in 104 patients (15,4%), of which 61 were women (9.0 %) 
and 43 men (6.4 %). Age in the new-onset AF group ranged from 30 to 93 years 
(mean 77.0 years). 18 (17.3%) of the patients with new-onset AF had a previously 
diagnosed paroxysmal AF with a new episode of AF at admission. The peak 
incidence of new-onset AF was on the second to third day of hospital stay. 
Of symptoms related to AF, such as dyspnea, palpitations, vertigo or syncope, the 
new-onset AF group reported the symptoms more often than the whole cohort. The 
AF episode was documented by 12-lead EKG in 86.5% of the cases, in the rest by a 
physician’s clinical diagnosis. The heart rate in these patients varied from 43 to 190 
with a mean of 122.  
Spontaneous conversion from AF to sinus rhythm occurred in 35 patients (33.7% of 
all AF patients), while 40 patients (38.5%) were treated pharmacologically before 
conversion to sinus rhythm, and 1 patient (1%) needed electrical (DC) conversion. 
The remainder (28 patients, 26.9%) persisted in AF.  
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Established risk factors for AF 
The frequencies of previously established cardiac risk factors for AF are listed in 
Table 2.  In both the new-onset AF group and in the group without new-onset AF, 
more than a half of the patients had cardiovascular disease at admission, either 
anamnestically or as documented by chest X-ray or echocardiography. In the entire 
patient cohort 47.7% had at least one of these conditions, while the corresponding 
number was 66.4% in the new-onset AF group.  
 
CRP as a possible risk factor for AF 
The CRP values on the day of admission ranged from 2 mg/L to 629 mg/L, with a 
median of 206.0 mg/L. In the new-onset AF subgroup the values ranged from 2 mg/L 
to 629 mg/L, with a median of 211.5 mg/L. The CRP-value distribution is shown in 
Figure 1. The majority of new-onset AF occurred on the day of admission. (Figure 2) 
Peak CRP values were reached during the two next days. 
The ROC curve of the diagnostic performance of the initial CRP-levels is depicted in 
Figure 3.  The areas under the curves were 0.55 and 0.53 for CRP levels treated as 
continuous and categorical variables, respectively. 
The observed odds ratios for new-onset AF in the three highest CRP-categories 
relative to the lowest were 1.34 (95% CI: 0.68-2.67), 1.28 (95% CI: 0.65-2.52) and 
1.47 (95% CI: 0.87-3.17), respectively. There was no significant trend in this figures 
(p = 0.24). Adjusting for earlier known cardiac risk factors did not have any impact on 
the estimates. 
CRP, atrial fibrillation and bacteremia 10
 
Concomitant corticosteroid treatment 
In the total patient group 34 patients had been taking oral corticosteroids 
(methylprednisolone > 10 mg) on a daily basis prior to the actual admission. Four of 
these patients had new-onset AF.  There was no significant difference between the 
new-onset AF group and the one without new onset AF. 
 
New-onset AF and survival 
46 persons died during the first four days after hospitalization. This number increased 
to 78 after two weeks. The percentage of patients still alive during the first two weeks 
after hospitalization is shown in Figure 4. The hazard ratio was 2.24 (95% CI: 1.37-
3.66, p=0.001) among patients with new-onset AF relative to patients without new-
onset AF. When adjusting for sex and age above 65 years the hazard ratio was 1.70 
(95% CI: 1.03-2.79, p=0.04).  
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Discussion 
While atrial fibrillation (AF) in clinical practice frequently is viewed as an indirect sign 
of infection, particularly in the elderly patients, this experience is not scientifically well 
documented. Postoperative AF, on the other hand, was reported as early as in the 
1970’ies.10 In one report analyzing patients after off-pump coronary artery bypass 
grafting (CABG), the frequency of postoperative AF in conjunction with an infection 
was 71.4%, in contrast to 21.4% if no infection was demonstrated microbiologically.11 
In another study of 460 unselected patients admitted to a surgical intensive care unit 
(ICU), significantly more patients with postoperative AF experienced sepsis and 
septic shock than the patients without postoperative AF.12  And in a large multi-center 
study of patients that underwent CABG, the only factor associated with infection was 
recurrent postoperative AF.13    
 
Our study, to our knowledge, is the first to report on the frequency of new-onset AF in 
a large population of patients with severe bacterial infection as apparently primary 
event. The finding of a 15.4% frequency of new-onset AF in this population is quite 
substantial, approximately equaling the reported incidence of postoperative AF after 
off-pump CABG (17.6%), after resection of colorectal cancer (13.7%) or cancer of the 
lung (19.8%). 14-16   It is somewhat lower than the incidence after conventional CABG 
(appr.30-40%) and after resection of cancer of the esophagus (22%).16;17 And it is 
definitely higher than the occurence after total hip or knee arthroplasty (3.1%).18  
 
The at least partial involvement of inflammation in the pathogenesis of AF seems to 
be widely acknowledged based on clinical, epidemiological, pharmacological and 
histological observations.19 These observations are related to both paroxysmal and 
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permanent AF, as well as new-onset AF after coronary surgery. Intriguingly, many of 
these studies are based on associations between AF and CRP. 
 
Our cohort of 677 patients with bacteremia with E.coli or S.pneumoniae is a 
population of indisputable high-grade inflammation. It may therefore appear 
astounding that no association between early CRP and increased risk of new-onset 
AF seems to materialize in our data. Neither did maximum CRP level coincide with 
peak incidence of new-onset AF. Baseline CRP is shown to be a risk indicator for AF 
after coronary surgery,20 and lowering of baseline CRP with atorvastatin appears to 
be effective in eliminating paroxysmal AF in a significant proportion of patients, 
although other mechanisms may be operative.21 It has also been shown that the 
maximum postoperative CRP level is reached on the same day as the peak 
incidence of AF.2 In the same study, however, the crude CRP levels on day 2 were 
not associated to AF. And despite the fact that interleukin-6 polymorphisms 
apparently affect the development of postoperative AF, early postoperative CRP 
does not.22 In yet another investigation scrutinizing AF after CABG there were no 
differences in the degree of the inflammatory response, included CRP, between 
patients who did and those who did not develop AF.23 
 
It is unknown to what extent the mechanisms for developing AF are the same in 
paroxysmal, permanent and new-onset AF. The discrepant results as regards CRP 
being a risk factor for AF in chronic, subclinical inflammation versus in acute 
inflammation, may point to different pathophysiologic mechanisms. Thus, statements 
on the association of inflammation, CRP and AF should be treated with caution. We 
do not doubt that inflammation be involved, but there is little evidence that CRP per 
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se has a pathophysiologic function in new-onset AF during acute inflammation. 
Rather, it seems that inflammatory mediators upstream of CRP may be involved 
through so-called innate immunity reactions. This notion is in agreement with the 
results of the aforementioned IL-6 polymorphism study, and the finding of a link 
between postoperative complement activation and postoperative AF.2;22   Further, 
experimental support of this view stems from the finding that arachidonic acid 
reduces conduction velocity in atrial tissue.24 In this context it is interesting to note 
one recent investigation showing that in the absence of elevated complement 
components, no statistical association was found between high CRP levels and 
permanent AF, challenging even the idea that CRP is closely associated to the 
development of permanent AF.25  
 
Corticosteroid therapy has been associated with reduced risk of recurrent and 
permanent AF, conceivably due to reduction of CRP.26 In an animal model of 
experimental sterile pericarditis methylprednisolone significantly reduced the 
incidence of AF.24 As corticosteroids have a broad anti-inflammatory action, we 
expected to find a lower incidence of new-onset AF in patients that had been treated 
with corticosteroids. However, we did not find such an association. On the other 
hand, the massive inflammatory chain of events during bacteremia may have 
overruled the anti-inflammatory action of a normal daily dose of methylprednisolone. 
Corticosteroid treatment is an unresolved issue in sepsis27, and indeed it has not 
been evaluated yet whether patients who are receive high doses of corticosteroids do 
have a lower incidence of new-onset AF than the ones without this treatment. 
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Chronic AF is associated with increased mortality, even after adjustment for 
preexisting cardiovascular conditions,28 as is postoperative AF.12;17;29;30   The level of 
increased mortality in these studies compares favorably to our finding of an almost 
doubled mortality risk in patients with new-onset AF as compared to those without 
new-onset AF. In the before mentioned study of new-onset AF following surgical 
esophagectomy,  AF was not the cause of death, leading the authors to conclude 
that atrial arrhythmias are simply markers of increased mortality and morbidity.17  
This is consistent with findings in trauma patients admitted to an ICU, in whom AF is 
associated with the systemic inflammatory response syndrome (SIRS), sepsis, acute 
renal failure and higher scores of disease severity. The authors of this study suggest 
that the onset of AF should be considered a surrogate marker of grave complications, 
rather than conferring a major effect on mortality in itself.29 
 
Taken together, the here presented results do not identify CRP as a predictor of new-
onset AF in patients suffering from bacteremia. On the other hand, the occurrence of 
AF during bacteremia should be viewed as a prognostic marker of adverse outcome. 
The issue of a possible association of inflammation, CRP and AF certainly deserves 
further scrutiny.  
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Tables and Figures 
 
Table 1 
Baseline characteristics    
 
Entire cohort 
  
Patients without new-onset AF 
 
Patients with new-onset AF 
 
 
(n=677) 
 (n=571) 
(n=104) 
 
Sex    
male 291 (43.0%) 248 (43.3%)  43 (41.3%) 
female 385 (56.9%) 324 (56.5%)  61 (58.7%) 
    
Age       
Age 20-64 229 (33.8%) 218 (38.0%)  11 (10.6%) 
Age 65-79 196 (29.0%) 154 (26.9%)  42 (40.4%) 
Age >80 252 (37.2%) 201 (35.1%)  51 (49.0%) 
    
Bacteria    
E.coli 450 (66.5%) 384 (67%)  66 (63.5%) 
S.pneumoniae 227 (33.5%) 189 (33%)  38 (36.5%) 
    
Symptoms     
Dyspnoe 135 (19.9%)   99 (17.3%)  36 (34.6%) 
Palpitations     4 (0.6%)     0 (0.0%)    4 (3.8%) 
Vertigo   39 (5.8%)     8 (4.9%)  11 (10.6%) 
Syncope   13 (1.9%)     9 (1.6%)    4 (3.8%) 
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Table 2 
  
Established risk factors for AF  
 
Entire cohort
 
Patients without
new-onset AF 
Patients with 
new-onset AFp-value* 
 
Permanent AF   38 (5.6%)   38 (6.6%)     0 (0.0%)  
Paroxysmal AF   40 (5.9%)   19 (3.3%)   21 (20.2%) <0.0005 
Myocardial infarction   90 (13.3%)   73 (12.7%)   17 (16.3%) 0.319 
Angina pectoris   93 (13.7%)   70 (12.2%)   23 (22.1%) 0.007 
Congestive heart failure   79 (11.7%)   62 (10.8%)   17 (16.3) 0.106 
Hypertension 152 (22.5%) 114 (19.9%)   38 (36.5%) <0.0005 
Cardiomyopathy   20 (3.0%)   12 (2.1%)     8 (7.7%) 0.002 
Hyperthyreosis     2 (0.3%)     2 (0.3%)     0 (0.0%) 0.546 
Cerebrovascular disease   94 (13.9%)   77 (13.4%)   17 (16.3%) 0.430 
COPD   72 (10.6%)   57 (9.9%)   15 (14.4%) 0.173 
Pulmonary embolism   10 (1.5%)   10 (1.7%)     0 (0.0%) 0.175 
Alcohol   46 (6.8%)   40 (7.0%)     6 (5.7%) 0.406 
Age > 65 years 443 (65.4%) 350 (61.1%)   93 (89.4%) <0.0005 
     
X-ray subgroup n=591 n=491 n=100  
Pulmonary venous congestion on x-ray 
  45 (7.6%)   37 (7.5%)    8 (8.0%)  
     
Echo subgroup n=69 n=48 n=21  
LVH on echocardiography   22 (31.9%)   19 (39.6%)    3 (14.3%)  
LVEF<45%   16 (34,0%)    9 (28,1%)    7 (46.7%)  
     
 
p-value* comparing patients with and without new-onset AF 
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Figure legends 
Figure 1. Distribution of CRP values on the day of admission 
 
Figure 2. Number of new onset AF and mean CRP at different days of hospital stay. 
 
Figure 3. Comparison of sensitivity and 1 – sensitivity for initial CRP levels measured 
both on continuous and categorical scale. 
 
Figure 4. Survival during the first two weeks after hospitalization 
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Figure 1. Distribution of CRP values on the day of admission 
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Figure 2 
 
 
 
 
0
10
20
30
40
50
60
70
Day 1 Day 2-3 Day 4-7
Ne
w
 o
ns
et
 A
F
0
50
100
150
200
250
300
M
ea
n 
CR
P
AF
CRP
 
Figure 2. Number of new onset AF and mean CRP at different days of hospital stay. 
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Figure 3 
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Figure 3. Comparison of sensitivity and 1 – sensitivity for initial CRP levels measured 
both on continuous and categorical scale. 
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Figure 4  
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Figure 4. Survival during the first two weeks after hospitalization 
 
 
 
 
 
 
 
 
 
